Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
European Review for Medical and Pharmacological Sciences, 21 (18), 42194227
It appears unlikely that maternal levocarnitine supplements during nursing would be harmful to the infant, but until more data are available, it is probably best to avoid levocarnitine supplementation unless a healthcare professional prescribes it
BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide
Duration of hair loss before treatment initiation affects outcomes significantly
US$ 25.50
US$ 20.53
US$ 24.01
US$ 25.13
US$ 20.33
US$ 22.52
US$ 22.01
US$ 25.83
